Cargando…
Approaches to accelerating the study of new antiretrovirals in pregnancy
INTRODUCTION: Women who are pregnant or who could become pregnant experience delayed access to or underinformed use of important new antiretroviral (ARV) drugs because of traditional drug development processes that ostensibly aim to reduce potential harm but effectively fail to ensure that timely in...
Autores principales: | Abrams, Elaine J., Calmy, Alexandra, Fairlie, Lee, Mahaka, Imelda C., Chimula, Lameck, Flynn, Patricia M., Kinuthia, John, Myer, Landon, Khoo, Saye H., Musoke, Philippa, Zwerski, Sheryl, Zech, Jennifer M., Lockman, Shahin, Siberry, George K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294864/ https://www.ncbi.nlm.nih.gov/pubmed/35851757 http://dx.doi.org/10.1002/jia2.25916 |
Ejemplares similares
-
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
por: Penazzato, Martina, et al.
Publicado: (2022) -
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
por: Fairlie, Lee, et al.
Publicado: (2019) -
Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023) -
Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy
por: Brummel, Sean S., et al.
Publicado: (2022) -
Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study
por: Myer, Landon, et al.
Publicado: (2012)